Development and commercialisation of a novel needle tract sealant system for pne...
Development and commercialisation of a novel needle tract sealant system for pneumothorax prevention during lung biopsy
Every 30sec someone somewhere globally dies of lung cancer. EU records ~320,000 pa new lung cancer cases. Early lung cancer diagnosis can save lives through timely/efficient interventions. CT guided lung biopsy is the gold standar...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
IJCI-2016-27595
Desarrollo de nuevas herramientas terapéuticas en cáncer de...
64K€
Cerrado
AMBULUNG
Ambulatory Bio Artificial Lung
7M€
Cerrado
PTQ2020-011049
Estudio del potencial preclínico del primer bioterapéutico r...
39K€
Cerrado
ENDOWAVE
ENDObronchial microWAVE Ablation for the minimally invasive...
71K€
Cerrado
PTQ2020-011048
Ingeniería y desarrollo de un nuevo pulmobioterapéutico pa...
39K€
Cerrado
TABLA
Development and Commercialisation of Transbronchial Lung Abl...
4M€
Cerrado
Información proyecto Selio System
Duración del proyecto: 24 meses
Fecha Inicio: 2022-09-28
Fecha Fin: 2024-09-30
Líder del proyecto
SELIO MEDICAL LIMITED
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Every 30sec someone somewhere globally dies of lung cancer. EU records ~320,000 pa new lung cancer cases. Early lung cancer diagnosis can save lives through timely/efficient interventions. CT guided lung biopsy is the gold standard for lung cancer screening. However, it comes with 62% inherent risk of life-threatening complication pneumothorax (PTX)- a complete or partial lung collapse. PTX sufferers require further radiological scans, needle aspiration, chest tube insertion or surgery- requiring additional hospital stay & ~€15k cost-of-care. Currently no method or device prevents PTX during the percutaneous needle access of lung.
Our patented Selio System will be world’s first system specifically designed to prevent PTX occurring before biopsy even takes place. Used by an interventional radiologist before lung biopsy procedure in a 2 min ‘add-on’ to the current standard of care, Selio System pre-seals the needle tract in tissue, thereby preventing air & blood leak from those organs